AGITG Research
The Australasian Gastro-Intestinal Trials Group (AGITG) is a not-for-profit organisation that facilitates and coordinates clinical trial research in GI cancer (cancer of the oesophagus, stomach, liver, gall bladder, pancreas and bowel) across Australasia and in the United Kingdom.
It is the only Australian clinical research organisation with the sole aim of improving health outcomes for people affected by GI cancers. The AGITG has participated in 26 GI cancer clinical trials since its inception in 1991; recruited more than 2,500 patients to investigator-initiated trials, contributing to best practice management of patients with GI cancer. Collaborating with institutions in Asia, Europe, Canada and the United States of America, the AGITG is fast becoming an internationally pre-eminent research organisation, recognised by its peers for exceptional conduct and reporting of important clinical research.
The AGITG has been instrumental in establishing networks of investigators capable of conducting multidisciplinary clinical research. In addition, the AGITG has established the necessary structures and processes to support the development and implementation of novel clinical research concepts. The aim is to facilitate the passage of experimental discoveries into state-of-the-art treatment by keeping to a minimum the time lapse between the discovery of new anti-cancer agents and their introduction into clinical use for patients with cancer.
The Group is made up of over 700 members - including surgeons, medical and radiation oncologists, gastroenterologists, nuclear medicine physicians, palliative care specialists, data managers, research nurses, pharmacists, statisticians, pathologists and other health professionals. These dedicated members are based at 69 hospitals and research centres across the globe. Membership has recently expanded to include Consumers and others interested in supporting the Group.
The AGITG was initially established as an unincorporated association in 1991, and formed as a company limited by guarantee in July 2000. The NHMRC Clinical Trials Centre at the University of Sydney is responsible for the coordination of AGITG clinical trials. The AGITG is committed to excellence, innovation and leadership in meeting the health care needs of the people it serves, improving community health and fostering the very best medical research.
AGITG Mission Statement
To continually achieve better health outcomes for patients with gastro-intestinal cancers by conducting and promoting clinical research, addressing key clinical questions.